Therapeutic options for the treatment of cancer-associated thrombosis.
OBJECTIVE
To provide oncology nurses with an understanding of therapeutic options for cancer-associated thrombosis, strategies to prevent recurrence, and practical issues in patient management.


METHODS
Primary and tertiary literature and the author's clinical experience.


CONCLUSIONS
Oncology nurses monitor patients throughout the care continuum for signs and symptoms indicating vascular thromboembolism and need to know the steps to take to expedite an accurate diagnosis and ensure prompt treatment.


CONCLUSIONS
Oncology nurses must keep informed about the evolving evidence that leads to practice changes. They should be able to teach patients about therapeutic options and their potential for improving outcomes.
Cunningham
Regina S
RS
The Cancer Institute of New Jersey, Department of Family Medicine, Research Division, Robert Wood Johnson Medical School, Piscataway, NJ, USA. rcunningham@umdnj.edu
D000925:Anticoagulants / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D009859:Oncology Nursing / Q000379:methods*; D012307:Risk Factors; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D014859:Warfarin